SEC Form 4 · accession 0001232524-15-000015
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Feb 10, 2015
Accepted (ET)
Feb 12, 2015 · 7:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 10, 2015 | M | 1,851 | $46.83 | A | 49,426 | D | |
| Ordinary Shares | Feb 10, 2015 | S | 1,851 | $166.90 | D | 47,575 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $46.83 | Feb 10, 2015 | M | 1,851 | D | — | Aug 8, 2022 | Ordinary Shares | 1,851 | 50,556 | D |
Explanation of responses
- F1The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 28,219 shares and will vest with respect to 12,805 shares in equal monthly installments from March 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.